Related references
Note: Only part of the references are listed.Genomic variation landscape of the human gut microbiome
Siegfried Schloissnig et al.
NATURE (2013)
Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
William R. Wikoff et al.
PLOS ONE (2013)
Metabolomics as a tool for personalizing medicine: 2012 update
Jinchun Sun et al.
PERSONALIZED MEDICINE (2013)
Liquid chromatography-mass spectrometry based global metabolite profiling: A review
Georgios A. Theodoridis et al.
ANALYTICA CHIMICA ACTA (2012)
Implementation of Molecular Phenotyping Approaches in the Personalized Surgical Patient Journey
Reza Mirnezami et al.
ANNALS OF SURGERY (2012)
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
Stefan Leucht et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
Vassilios Fanos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy
Jeremy K. Nicholson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
The human gut microbiome: the ghost in the machine
Audrey Feeney et al.
FUTURE MICROBIOLOGY (2012)
Pharmaco-metabolomics: An emerging omics tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets
Giuseppe Corona et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Targeting the Human Genome-Microbiome Axis for Drug Discovery: Inspirations from Global Systems Biology and Traditional Chinese Medicine
Liping Zhao et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Pharmacometabonomic Investigation of Dynamic Metabolic Phenotypes Associated with Variability in Response to Galactosamine Hepatotoxicity
Muireann Coen et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Pharmacometabonomic Characterization of Xenobiotic and Endogenous Metabolic Phenotypes That Account for Inter-individual Variation in Isoniazid-Induced Toxicological Response
Katharine Cunningham et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Novel biomarkers for pre-diabetes identified by metabolomics
Rui Wang-Sattler et al.
MOLECULAR SYSTEMS BIOLOGY (2012)
A framework for human microbiome research
Barbara A. Methe et al.
NATURE (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
Metabolic phenotyping in clinical and surgical environments
Jeremy K. Nicholson et al.
NATURE (2012)
Prediction of the Pharmacokinetic Parameters of Triptolide in Rats Based on Endogenous Molecules in Pre-Dose Baseline Serum
Linsheng Liu et al.
PLOS ONE (2012)
Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
Miles Trupp et al.
PLOS ONE (2012)
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics
Ryan Abo et al.
PHARMACOGENETICS AND GENOMICS (2012)
Impact of Intestinal Microbiota on Intestinal Luminal Metabolome
Mitsuharu Matsumoto et al.
SCIENTIFIC REPORTS (2012)
Personalised medicine: not just in our genes
Georgios D. Kitsios et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Characterization of surgical aerosols by the compact single-particle mass spectrometer LAMPAS 3
K. -P. Hinz et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
In Situ, Real-Time Identification of Biological Tissues by Ultraviolet and Infrared Laser Desorption Ionization Mass Spectrometry
Karl-Christian Schaefer et al.
ANALYTICAL CHEMISTRY (2011)
The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains
Lisa F. Dawson et al.
BMC MICROBIOLOGY (2011)
Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review
Aurelie Roux et al.
CLINICAL BIOCHEMISTRY (2011)
Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
Alexandra Backshall et al.
CLINICAL CANCER RESEARCH (2011)
Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics
Y. Ji et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
Ruth Condray et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
The Footprints of Gut Microbial-Mammalian Co-Metabolism
Xiaojiao Zheng et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach
Hyuk Nam Kwon et al.
KIDNEY INTERNATIONAL (2011)
Metabolic phenotyping for monitoring surgical patients
James M. Kinross et al.
LANCET (2011)
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Denis V. Titov et al.
NATURE CHEMICAL BIOLOGY (2011)
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Rima Kaddurah-Daouk et al.
PLOS ONE (2011)
Methodological quality in pharmacogenetic studies with binary assessment of treatment response: a review
Albert Cobos et al.
PHARMACOGENETICS AND GENOMICS (2011)
Pharmacoproteomics of obesity: definitions, role and a case study of dynamics of human plasma proteome
Victor P. Andreev
PHARMACOGENOMICS (2011)
Pharmacometabonomics as an effector for personalized medicine
Jeremy K. Nicholson et al.
PHARMACOGENOMICS (2011)
Understanding the role of gut microbiome-host metabolic signal disruption in health and disease
Elaine Holmes et al.
TRENDS IN MICROBIOLOGY (2011)
Gut microbiome-host interactions in health and disease
James M. Kinross et al.
GENOME MEDICINE (2011)
Consensus-Phenotype Integration of Transcriptomic and Metabolomic Data Implies a Role for Metabolism in the Chemosensitivity of Tumour Cells
Rachel Cavill et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
R. Kaddurah-Daouk et al.
TRANSLATIONAL PSYCHIATRY (2011)
Use of Pharmaco-Metabonomics for Early Prediction of Acetaminophen-Induced Hepatotoxicity in Humans
J. H. Winnike et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
An Integrative Approach for Identifying a Metabolic Phenotype Predictive of Individualized Pharmacokinetics of Tacrolimus
P. B. Phapale et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Pharmacoproteomics: a chess game on a protein field
Angelo D'Alessandro et al.
DRUG DISCOVERY TODAY (2010)
Global metabolic profiling procedures for urine using UPLC-MS
Elizabeth J. Want et al.
NATURE PROTOCOLS (2010)
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
Rima Kaddurah-Daouk et al.
METABOLOMICS (2010)
Cost Effectiveness of Pharmacogenomics A Critical and Systematic Review
William B. Wong et al.
PHARMACOECONOMICS (2010)
Systematic review of pharmacoeconomic studies of pharmacogenomic tests
Mathieu Beaulieu et al.
PHARMACOGENOMICS (2010)
Pharmacogenomics: a systems approach
Liewei Wang
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2010)
Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
Hector C. Keun et al.
CLINICAL CANCER RESEARCH (2009)
The Gut Microbiota as a Target for Improved Surgical Outcome and Improved Patient Care
James Kinross et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Drugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring
Ian D. Wilson
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
T. Andrew Clayton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Spectroscopic and Statistical Techniques for Information Recovery in Metabonomics and Metabolomics
John C. Lindon et al.
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY (2008)
Metabolomics: A global biochemical approach to drug response and disease
Rima Kaddurah-Daouk et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: Challenges and implications
Louis P. Garrison et al.
DRUG METABOLISM REVIEWS (2008)
Gas chromatography/mass spectrometry in metabolic profiling of biological fluids
Kishore K. Pasikanti et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Symbiotic gut microbes modulate human metabolic phenotypes
Min Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ambient desorption ionization mass spectrometry
Andre Venter et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2008)
Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals
Serge Rezzi et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Metabolomic mapping of atypical antipsychotic effects in schizophrenia
R. Kaddurah-Daouk et al.
MOLECULAR PSYCHIATRY (2007)
Translating pharmacogenomics: Challenges on the road to the clinic
Jesse J. Swen et al.
PLOS MEDICINE (2007)
Detection of urinary drug metabolite (Xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy
Elaine Holmes et al.
ANALYTICAL CHEMISTRY (2007)
P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production
Eva Schepers et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats
Houkai Li et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics
Daniel W. Nebert et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily - A randomized controlled trial
Paul B. Watkins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Pharmaco-metabonomic phenotyping and personalized drug treatment
TA Clayton et al.
NATURE (2006)
Human sulfotransferases and their role in chemical metabolism
N Gamage et al.
TOXICOLOGICAL SCIENCES (2006)
Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS
JM Halket et al.
JOURNAL OF EXPERIMENTAL BOTANY (2005)
Role of pharmacoproteomics in the development of personalized medicine
KK Jain
PHARMACOGENOMICS (2004)
Understanding 'global' systems biology: Metabonomics and the continuum of metabolism
JK Nicholson et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Metabolomics - the link between genotypes and phenotypes
O Fiehn
PLANT MOLECULAR BIOLOGY (2002)
Orthogonal projections to latent structures (O-PLS)
J Trygg et al.
JOURNAL OF CHEMOMETRICS (2002)
Potential role of pharmacogenomics in reducing adverse drug reactions - A systematic review
KA Phillips et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Pharmacogenomics: Unlocking the human genome for better drug therapy
HL McLeod et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Metabolite profiling for plant functional genomics
O Fiehn et al.
NATURE BIOTECHNOLOGY (2000)
Clinical chemistry of serotonin and metabolites
IP Kema et al.
JOURNAL OF CHROMATOGRAPHY B (2000)
Share Paper
